How much longer until Bridion is FDA approved?

[Guest guest]

Looks like only a short wait for our practices to change significantly.

EU OKs Drug to Reverse Neuromuscular Blockade

By Ransdell Pierson

NEW YORK (Reuters) Jul 30 - European regulators have approved a

breakthrough new medication to help patients emerge far more quickly

from anesthesia than existing treatments, the drug's maker

Schering-Plough Corp said on Tuesday.

The drug, called Bridion, was approved by the European Commission,

following a recommendation last month by an advisory panel in support

of the drug, also known as sugammadex.

Bridion was approved for reversal of neuromuscular block induced by rocuronium

and vecuronium.

The medicine is awaiting approval in the United States. An advisory

panel to the U.S. Food and Drug Administration in March voted that it

was safe and effective.

In a late stage clinical trial, Bridion reversed the effects

neuromuscular blockade within a few minutes -- nine to 12 times faster

than the standard reversal agent, neostigmine, according to researchers.

________________________________

Reuters Health Information 2008. © 2008 Reuters Ltd.

Republication

or redistribution of Reuters content, including by framing or similar

means, is expressly prohibited without the prior written consent of

Reuters. Reuters shall not be liable for any errors or delays in the

content, or for any actions taken in reliance thereon. Reuters and the

Reuters sphere logo are registered trademarks and trademarks of the

Reuters group of companies around the world.

, DO